User:Scott H. Vanson/Sandbox 1

From Proteopedia

Revision as of 15:01, 1 May 2018

DNA Polymerase θ

spinqualitylabelsall models PDB ID 4x0p Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image use of JSmol in Proteopedia [1] article describing Jmol [2] Contents 1 General Description 2 Structural Highlights 2.1 ddATP Opposite THF 2.2 dCMP Opposite ddGTP 3 Structural Insights into Function 3.1 Proofreading Activity 3.2 Translesion Synthesis 3.2.1 Sticky Thumb 4 Related Proteins General Description Human polymerase θ (pol θ) is large, 290kD enzyme consisting of three distinct domains [3][4]. An N-terminal helicase-like domain, whose exact cellular functions are a topic of on-going debate and research[5][6], is linked to a C-terminal, family A DNA polymerase domain by a large and disordered central region[4]. Notably, pol θ is the only known human polymerase to contain a polymerase and helicase domain in one molecule[7]. Crystal structures have been solved for the apo form of the helicase-like domain and the ternary complex of the polymerase domain. The focus of this wiki is the polymerase domain. Pol θ is thought to promote overall genomic stability by performing several distinct cellular functions. The primary role of the enzyme is to repair of double-stranded DNA breaks as the key enzyme in an error-prone non-homologous end-joining pathway called alternative end-joining[8] or theta-mediated end-joining. Other functions include translesion synthesis, the ability of the polymerase to bypass and extend past a site of oxidative DNA damage[9], base excision repair [10], and possibly DNA replication timing [11]. Pol θ has the specialized ability to extend DNA from minimally-paired primers (termed microhomologous)Template:Cn. Repair by this enzyme is considered to error-prone due to its tendency to add or delete short indels [8]. Several types of cancer, such as breast, ovarian, and oral carcinomas, have shown significantly higher expression levels of pol θ and correlate to poorer patient outcomes[12][13][14]. Genomic studies have shown that more than half of epithelial ovarian cancers have defects in the error-free repair pathway of homologous recombination[15] and, as a result, have an increased dependence on theta-mediated end-joining [12]. Double-stranded break repair by pol θ may be thought of as a "backup" pathway which cells depend on more when the machinery involved in homologous recombination is compromised or otherwise unavailable. This enzyme has been identified as a potential therapeutic target due to overexpression in cancers in combination with studies that have shown inhibition of pol θ to sensitize human and mouse cells to radiation and chemical agents which induce double-stranded breaks[12][16][17]. Structural Highlights Two crystal structures of the polymerase domain have been solved bound, inserting ddATP opposite tetrahydrofuran (THF, representing an abasic site) and inserting ddGTP opposite dCMP[7]. An overall assessment of the structures display the canonical . The DNA is thought to "sit" on the palm and is enclosed by the thumb and fingers which contact the minor groove. The closed conformation of the polymerase domain becomes obvious when compared to the , such as Thermus aquaticus DNA polymerase I. ddATP Opposite THF An inspection of the active site reveals the , in this instance calcium. This structure required the use of calcium, a known inhibitor of polymerase activity, as the primer strand retains the 3' hydroxyl which would otherwise be subjected to nucleophilic attack. The similarly conserved . dCMP Opposite ddGTP from the same study was solved with magnesium as the coordinated metal, a 27 amino acid N-terminal truncation, and a blunted DNA oligomer to remove the 3' template overhang. The overall structure is virtually identical to the aforementioned structure complexed with calcium, with the exception of a slight shift in position of the O-helix to be closer to the cognate C:G basepair. Alignment of O-helices and incoming nucleotides. Mg complex (yellow) shifts slightly closer to incoming ddGTP than Ca complex (red) relative to its incoming ddATP. Structural Insights into Function Proofreading Activity Family A DNA polymerases harbor an N-terminal exonuclease domain and generally conserve the overall fold. Some members of this family, e.g. E. coli pol I, display active 3'-5' proofreading activity via . Other members, such as pol θ, do not harbor proofreading activity[7] and at equivalent positions differ in identity and arrangement. Translesion Synthesis An R2254V variant was made to investigate the importance of this residue in pol θ's ability to extend single-stranded DNA and bypass abasic sites and bulky thymine glycol lesions. Thymine may oxidized to form a bulky lesion that must be repaired or bypassed. Bacterial family A polymerases which do not have this ability retain a val or leu at the equivalent position. The R2254V mutant retained its ability to extend double-stranded but not single-stranded DNA and also was not able to bypass abasic sites or thymine glycol. These findings indicated to the authors that is required to compensate for the missing contacts to the template strand due to a lesion[7]. Sticky Thumb In addition to R2254, additional upstream contacts to the primer DNA strand mediated by and of the thumb subdomain can be observed. These three salt bridges provide specialized contacts that are not observed in other family A polymerases, in addition to R2201 and R2315 which are also present in pol ν and pol I. Alanine substitutions of K2181, R2202, and R2254 resulted in inhibition of pol θ's ability to bypass an abasic site or thymine glycol. These findings prompted the authors to assert that this may be responsible for the heightened ability of pol θ to synthesize across lesions and to extend from minimally-paired primers[7]. Related Proteins

References

1. Yousefzadeh MJ, Wood RD. DNA polymerase POLQ and cellular defense against DNA damage. DNA Repair (Amst). 2013; 12:1–9. [PubMed: 23219161] 2. Seki M, Marini F, Wood RD. POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res. 2003; 31:6117–6126. [PubMed: 14576298] 3. Sfeir RPA 4. Pomerantz Helicase PMID:29444826 5. Zahn 6. Newman 6. Yousefzadeh MJ, et al. Mechanism of Suppression of Chromosomal Instability by DNA Polymerase POLQ. PLoS Genet. 2014; 10:e1004654. [PubMed: 25275444] 7. Yoon JH, Roy Choudhury J, Park J, Prakash S, Prakash L. A role for DNA polymerase theta in promoting replication through oxidative DNA lesion, thymine glycol, in human cells. J Biol Chem. 2014; 289:13177–13185. [PubMed: 24648516] 8. Asagoshi K, et al. Single-nucleotide base excision repair DNA polymerase activity in C. elegans in the absence of DNA polymerase beta. Nucleic Acids Res. 2012; 40:670–681. [PubMed: 21917855] 9. Fernandez-Vidal A, et al. A role for DNA polymerase theta in the timing of DNA replication. Nat Commun. 2014; 5:4285. [PubMed: 24989122] 10. Ceccaldi 11. Lemee F, et al. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci U S A. 2010; 107:13390–13395. [PubMed: 20624954] 12. Lessa RC, et al. Identification of upregulated genes in oral squamous cell carcinomas. Head Neck. 2013; 35:1475–1481. [PubMed: 22987617] 13. Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474:609–615.10.1038/nature10166 14. Goff JP, et al. Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiat Res. 2009; 172:165–174. [PubMed: 19630521] 15. Higgins GS, et al. A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res. 2010; 70:2984–2993. [PubMed: 20233878]

1. ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
2. ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
3. ↑ Yousefzadeh MJ, Wood RD. DNA polymerase POLQ and cellular defense against DNA damage. DNA Repair (Amst). 2013 Jan 1;12(1):1-9. doi: 10.1016/j.dnarep.2012.10.004. Epub , 2012 Dec 4. PMID:23219161 doi:http://dx.doi.org/10.1016/j.dnarep.2012.10.004
4. ↑ ^{4.0 4.1} Seki M, Marini F, Wood RD. POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res. 2003 Nov 1;31(21):6117-26. PMID:14576298
5. ↑ Mateos-Gomez PA, Kent T, Deng SK, McDevitt S, Kashkina E, Hoang TM, Pomerantz RT, Sfeir A. The helicase domain of Poltheta counteracts RPA to promote alt-NHEJ. Nat Struct Mol Biol. 2017 Dec;24(12):1116-1123. doi: 10.1038/nsmb.3494. Epub 2017, Oct 23. PMID:29058711 doi:http://dx.doi.org/10.1038/nsmb.3494
6. ↑ Ozdemir AY, Rusanov T, Kent T, Siddique LA, Pomerantz RT. Polymerase theta-helicase efficiently unwinds DNA and RNA-DNA hybrids. J Biol Chem. 2018 Apr 6;293(14):5259-5269. doi: 10.1074/jbc.RA117.000565. Epub, 2018 Feb 14. PMID:29444826 doi:http://dx.doi.org/10.1074/jbc.RA117.000565
7. ↑ ^{7.0 7.1 7.2 7.3 7.4} Nussbaum J, Zane EA, Thys DM. Esmolol for the treatment of hypercyanotic spells in infants with tetralogy of Fallot. J Cardiothorac Anesth. 1989 Apr;3(2):200-2. PMID:2577526
8. ↑ ^{8.0 8.1} PubMed:25275444
9. ↑ PubMed:24648516
10. ↑ PubMed:21917855
11. ↑ PubMed:24989122
12. ↑ ^{12.0 12.1 12.2} Ceccaldi R, Liu JC, Amunugama R, Hajdu I, Primack B, Petalcorin MI, O'Connor KW, Konstantinopoulos PA, Elledge SJ, Boulton SJ, Yusufzai T, D'Andrea AD. Homologous-recombination-deficient tumours are dependent on Poltheta-mediated repair. Nature. 2015 Feb 12;518(7538):258-62. doi: 10.1038/nature14184. Epub 2015 Feb 2. PMID:25642963 doi:http://dx.doi.org/10.1038/nature14184
13. ↑ PubMed:20624954
14. ↑ PubMed:22987617
15. ↑ . Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166. PMID:21720365 doi:http://dx.doi.org/10.1038/nature10166
16. ↑ PubMed:19630521
17. ↑ PubMed:20233878